Login / Signup

African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies.

Mark A Fiala
Published in: Cancer (2019)
Keyphrases
  • african american
  • monoclonal antibody
  • end stage renal disease
  • ejection fraction
  • patient reported outcomes
  • combination therapy
  • patient reported